Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Opus Genetics, Inc. (IRD) had Operating Cash Flow per Share of $-0.57 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$14.20M |
|
$-49.59M |
|
-- |
|
$14.20M |
|
$52.80M |
|
$-38.60M |
|
$-10.99M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-38.60M |
|
$-38.55M |
|
62.22M |
|
62.22M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$50.04M |
|
$0.20M |
|
$0.20M |
|
$50.24M |
|
$7.78M |
|
-- |
|
$27.11M |
|
$34.90M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
69.89M |
|
| Cash Flow Statement Financials | |
$-35.25M |
|
-- |
|
$50.02M |
|
$30.32M |
|
$45.09M |
|
$14.77M |
|
$3.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-271.90% |
|
-271.90% |
|
-271.53% |
|
-349.33% |
|
-349.33% |
|
$-35.25M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
7.12 |
|
51.29 |
|
-323.11% |
|
-323.11% |
|
-98.70% |
|
-323.11% |
|
$0.22 |
|
$-0.57 |
|
|
Operating Cash Flow per Share |
$-0.57 |